Q2 2023 13F Holders as of 6/30/2023
-
Type / Class
-
Equity / Common Stock, par value $0.001 per share
-
Shares outstanding
-
58.9M
-
Number of holders
-
183
-
Total 13F shares, excl. options
-
56.1M
-
Shares change
-
-2.25M
-
Total reported value, excl. options
-
$369M
-
Value change
-
-$15.1M
-
Put/Call ratio
-
1.5
-
Number of buys
-
94
-
Number of sells
-
-72
-
Price
-
$6.59
Significant Holders of Vanda Pharmaceuticals Inc. - Common Stock, par value $0.001 per share (VNDA) as of Q2 2023
200 filings reported holding VNDA - Vanda Pharmaceuticals Inc. - Common Stock, par value $0.001 per share as of Q2 2023.
Vanda Pharmaceuticals Inc. - Common Stock, par value $0.001 per share (VNDA) has 183 institutional shareholders that have filed 13F forms with the Securities Exchange Commission (SEC).
These institutions hold a total of 56.1M shares
of 58.9M outstanding shares and own 95.21% of the company stock.
Largest 10 shareholders include BlackRock Inc. (10.8M shares), VANGUARD GROUP INC (4.24M shares), STATE STREET CORP (4.08M shares), RENAISSANCE TECHNOLOGIES LLC (3.11M shares), GOLDMAN SACHS GROUP INC (2.1M shares), DIMENSIONAL FUND ADVISORS LP (1.95M shares), Assenagon Asset Management S.A. (1.59M shares), PICTET ASSET MANAGEMENT SA (1.57M shares), D. E. Shaw & Co., Inc. (1.28M shares), and HOTCHKIS & WILEY CAPITAL MANAGEMENT LLC (1.26M shares).
This table shows the top 183 institutional shareholders of the company equity. This data is sourced directly from the SEC via 13F filings.
| Investor |
Option |
Weight % |
Change % |
Value $ |
* Price $ |
Shares |
Share Change |
Activity |
Report Period |
* Reported Price is the price of the security as of the portfolio date. This value is significant in that it is the last known price at which the security was still held.
An asterisk sign (*) next to the price indicates that the price is likely invalid.